Telomeric lengths and telomerase activity in liposarcomas

Molecular Carcinogenesis

Volumn 24, Issue 2, 1999, Pages 144-151

  Schneider Stock, Regine ^a   Epplen, Joerg T ^b   Walter, Hajo ^a   Radig, Kathrin ^a   Rys, Janusz ^c   Epplen, Cornelia ^b   Hoang Vu, Cuong ^d   Niezabitowski, Alexander ^c   Roessner, Albert ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c INSTITUTE OF ONCOLOGY   (Poland)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Liposarcoma; Telomerase activity; Telomere lengths

Indexed keywords

TELOMERASE;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; HUMAN; LIPOSARCOMA; MALE; MITOSIS INDEX; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TELOMERE;

ADULT; AGED; ENZYME ACTIVATION; FEMALE; HUMANS; LIPOSARCOMA; MALE; MIDDLE AGED; NEOPLASM METASTASIS; TELOMERASE; TELOMERE;

EID: 0032968874     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199902)24:2<144::AID-MC9>3.0.CO;2-7     Document Type: Article

References (38)

1. Killian A, Bowtell DDL. Abud HE, et al. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 1997;6:2011-2019.
2. Counter CM. Avilion AA, Le Feuvre CE, et al. Telomere shortening associated with chromosome instability in immortal cells which express telomerase activity. EMBO J 1992;11:1921-1929.
3. Harley CB, Kim NW, Prowse KR, et al. Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol 1994;59:307-315.
4. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-2015.
5. Hiyama E, Gollahon L, Kataoka T. Telomerase activity in human breast tumors. J Natl Cancer Inst 1996;88:116-122.
6. Hiyama E, Hiyama K, Ishioka S, et al. Telomerase activity in small-cell and in non-small-cell lung cancers. J Natl Cancer Inst 1995;87:895-901.
7. Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova GS, Shay JW, Coffey DS. Telomerase activity: A prevalent marker of malignant human prostate tissue. Cancer Res 1996;56:218-222.
8. Tahara H, Kuniyasu H, Yokazaki H, et al. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin Cancer Res 1995;1:1245-1251.
9. Hiyama E, Yokoyama T, Tatsumoto N, et al. Telomerase activity in gastric cancer. Cancer Res 1995;55:3258-3262.
10. Brien TP, Kallakury VS, Lowry CV, et al. Telomerase activity in benign endometrium and endometrial carcinoma. Cancer Res 1997;57:2760-2764.
11. Langford LA, Piatyszek MA, Xu RS, Schold SC, Shay JW. Telomerase activity in human brain tumors. Lancet 1995; 346:1267-1268.
12. Haugen BR, Nawaz S, Markham N, et al. Telomerase actvity in benign and malignant thyroid tumors. Thyroid 1997;7:337-342.
13. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity with human neuroblastoma outcomes. Nat Med 1:249-255, 1995.
14. Schneider-Stock R, Epplen C, Radig K, et al. On telomere shortening in soft tissue tumors J Cancer Res Clin Oncol 1998; 124:165-171.
15. Fletcher CD, Akerman M, DalCin P, et al. Correlation between clinicopathological features and karyotype in lipomatous tumors: A report of 178 cases from the chromosomes and morphology (CHAMP) collaborative study group. Am J Pathol 1996;148:623-630.
16. Trojani M, Contesso G, Coindre JM, et al. Soft tissue sarcomas of adults: Study of pathological prognostic variables and definition of a histopathological grading system Int J Cancer 1984;33:37-42.
17. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: A Laboratory manual, 2nd edition. Cold Spring Harbor: Cold Spring Harbor Press: 1989.
18. Epplen JT. The methodology of multilocus DNA fingerprinting using radioactive or nonradioactive oligonucleotide probes specific for simple repeat motifs. Advances in Electrophoresis 1992;5:59-112.
19. Piatyszek MA, Kim NW, Weinrich SL, et al. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci 1995;17:1-15.
20. Holt SE, Norton JC, Wright WE, Shay JW. Comparison of the Telomeric Repeat Amplification Protocol (TRAP) to the new TRAP-eze™ Telomerase Detection Kit. Methods Cell Biol 1996;18:237-248.
21. deLange T. Activation of telomerase in a human tumor. Proc Natl Acad Sci USA 1994;91:2882-2885.
22. Counter CM, Hirte HW, Bacchetti S, Harley CB Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994;91:2900-2904.
23. Mehle C, Ljungberg B, Roos G. Telomere shortening in renal cell carcinoma. Cancer Res 1994;54:236-241.
24. Örndal C, Rydholm A, Willen H, Mitelman F, Mandahl N. Cytogenetic intratumor heterogeneity in soft tissue tumors. Cancer Genet Cytogenet 1994;78.127-137.
25. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997;33:787-791.
26. Kim NW. Clinical implications of telomerase in cancer Eur J Cancer 1997;33:781-786.
27. Ahn MJ, Noh YH, Lee YS, et al Telomerase activity and its clinicopathological significance in gastric cancer. Eur J Cancer 1997;33:1309-1313.
28. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995;55:2533-2536.
29. Murakami J, Nagai N, Ohama K, Tahara H, Ide T. Telomerase activity in ovarian tumors. Cancer 1997;80:1085-1092.
30. Vaziri H, Benchimol S. From telomere loss to p53 induction and activation of a DMA-damage pathway at senesce: The telomere loss/DMA damage model of cell aging. Exp Gerontol 1996 31;295-301.
31. Bednarek A, Budunova I, Slaga TJ, Aldaz CM. Increased telomerase activity in mouse skin premalignant progression. Cancer Res 1995;55:4566-4569.
32. Blasco MA, Funk W, Villeponteau B, Greider CW. Functional characterization and developmental regulation of mouse telomerase RNA. Science 1995;269:1267-1270,
33. Rushing EJ, Yashima K, Brown D, et al. Expression of telomerase RNA component correlates with the MIB-1 proliferation index in ependymomas. J Neuropathol Exp Neurol 1997;56:1142-1146.
34. Sallinen P, Miettinen H, Sallinen SL, Haapasalo H, Helin H, Kononen J. Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas. Am J Pathol 1997;150:1159-1164.
35. Sreekantaiah C, Ladanyi M, Rodriguez E, Chaganti RSK. Chromosomal aberrations in soft tissue tumors: Relevance to diagnosis, classification, and molecular mechanisms. Am J Pathol 1994;144:1121-1134.
36. Enzinger FM, Weiss SW. Soft tissue tumors, 3rd edition St Louis: Mosby; 1995;381-466.
37. Rubin BP, Fletcher CD. The cytogenetics of lipomatous tumours Histopathology 1997;30:507-511.
38. Mentzel T, Fletcher CD. Lipomatous tumours of soft tissues: An update. Virchows Arch 1995;427:353-363.